Europe has launched the Joint Action on Personalized Cancer Medicine, involving 29 countries and over 140 partners, to improve prevention, diagnosis, and treatment through data-driven, individualized...
Amgen's AMG 510 was a highlight at the 2019 American Society of Clinical Oncology meeting.